HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Time to extubation for lung transplant recipients represents a pragmatic end-point to guide the development of prognostic tests.

Abstract
The field of transplantation would benefit from the integration of advanced precision medicine techniques. Although predictive tests for lung transplantation require a well-defined clinical end-point, there exists no consensus regarding which outcomes are optimal end-points for these purposes. While many possible candidate end-points exist, we propose that time-to-extubation is an optimal end-point for prognostic tests because of its: clinical relevance; objectiveness; stability over time; and association with healthcare expenditure. Herein, we describe the rationale for this selection and present the limitations of alternative outcomes for this purpose. Using a 72-hour cut-off, time to extubation correlated well with Primary Graft Dysfunction Grade 3, intensive care unit and hospital length of stay, and a greater than 2-fold increase in healthcare cost ratios. Given that time-to-extubation is an objective measure that is readily measured by all lung transplant centers, this metric represents a preferred primary end-point for prognostic tests developed for lung transplantation.
AuthorsAndrew T Sage, John Peel, Jerome Valero, Jonathan C Yeung, Mingyao Liu, Marcelo Cypel, Beate Sander, Shaf Keshavjee
JournalThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation (J Heart Lung Transplant) Vol. 42 Issue 11 Pg. 1515-1517 (11 2023) ISSN: 1557-3117 [Electronic] United States
PMID37406839 (Publication Type: Journal Article)
CopyrightCopyright © 2023 International Society for the Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.
Topics
  • Humans
  • Prognosis
  • Airway Extubation
  • Transplant Recipients
  • Lung
  • Lung Transplantation (methods)
  • Retrospective Studies
  • Length of Stay

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: